{"version":"1.0","type":"link","title":"Advances in Targeted Therapy for Human Epidermal Growth Factor Receptor 2-Low Tumors: From Trastuzumab to Antibody-Drug Conjugates.","author_name":"Zheng ZN 외","author_url":"https://prs-insight.online/author/Zheng%20ZN","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/78336","thumbnail_width":1200,"thumbnail_height":630}